BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31274235)

  • 21. Incidence of stage 3 chronic kidney disease and progression on tenofovir-based regimens.
    Zachor H; Machekano R; Estrella MM; Veldkamp PJ; Zeier MD; Uthman OA; Taljaard JJ; Moosa MR; Nachega JB
    AIDS; 2016 May; 30(8):1221-8. PubMed ID: 26836786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal outcomes after up to 8 years of tenofovir exposure in HIV-HBV-coinfected patients.
    Boyd A; Miailhes P; Lascoux-Combe C; Rougier H; Girard PM; Plaisier E; Lacombe K
    Antivir Ther; 2017; 22(1):31-42. PubMed ID: 27553871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) chronic kidney disease risk score in HIV-infected patients in the USA.
    Mills AM; Schulman KL; Fusco JS; Brunet L; Hsu R; Beyer A; Prajapati G; Mounzer K; Fusco GP
    HIV Med; 2020 May; 21(5):299-308. PubMed ID: 31985887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cystatin C and baseline renal function among HIV-infected persons in the SUN Study.
    Overton ET; Patel P; Mondy K; Bush T; Conley L; Rhame F; Kojic EM; Hammer J; Henry K; Brooks JT;
    AIDS Res Hum Retroviruses; 2012 Feb; 28(2):148-55. PubMed ID: 21480819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal function and incidence of chronic kidney disease in HIV patients: a Danish cohort study.
    Rasch MG; Engsig FN; Feldt-Rasmussen B; Kirk O; Kronborg G; Pedersen C; Gerstoft J; Obel N
    Scand J Infect Dis; 2012 Sep; 44(9):689-96. PubMed ID: 22680981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of renal disease within an urban HIV-infected cohort in northern Italy.
    Calza L; Vanino E; Magistrelli E; Salvadori C; Cascavilla A; Colangeli V; Di Bari MA; Manfredi R; Viale P
    Clin Exp Nephrol; 2014 Feb; 18(1):104-12. PubMed ID: 23712539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic Kidney Disease and Antiretroviral Therapy in HIV-Positive Individuals: Recent Developments.
    Achhra AC; Nugent M; Mocroft A; Ryom L; Wyatt CM
    Curr HIV/AIDS Rep; 2016 Jun; 13(3):149-57. PubMed ID: 27130284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of chronic kidney disease and utility of risk prediction scores in HIV-positive individuals.
    Woolnough EL; Hoy JF; Cheng AC; Walker RG; Chrysostomou A; Woolley I; Langham F; Moso MA; Weeraratne A; Trevillyan JM
    AIDS; 2018 Aug; 32(13):1829-1835. PubMed ID: 29847332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advanced chronic kidney disease, end-stage renal disease and renal death among HIV-positive individuals in Europe.
    Ryom L; Kirk O; Lundgren JD; Reiss P; Pedersen C; De Wit S; Buzunova S; Gasiorowski J; Gatell JM; Mocroft A;
    HIV Med; 2013 Sep; 14(8):503-8. PubMed ID: 23590641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Classification of human immunodeficiency virus-infected patients with chronic kidney disease using a combination of proteinuria and estimated glomerular filtration rate.
    Yanagisawa N; Muramatsu T; Yamamoto Y; Tsuchiya K; Nitta K; Ajisawa A; Fukutake K; Ando M
    Clin Exp Nephrol; 2014 Aug; 18(4):600-5. PubMed ID: 23955325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of Chronic Kidney Disease among Patients Developing Mild Renal Impairment during Tenofovir-Containing Antiretroviral Treatment.
    Lapadula G; Bernasconi DP; Casari S; Maggiolo F; Cauda R; Di Pietro M; Ladisa N; Sighinolfi L; Dal Zoppo S; Sabbatini F; Soria A; Pezzoli C; Mondi A; Costarelli S; Valsecchi MG; Torti C; Gori A;
    PLoS One; 2016; 11(9):e0162320. PubMed ID: 27632369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study.
    Ryom L; Mocroft A; Kirk O; Worm SW; Kamara DA; Reiss P; Ross M; Fux CA; Morlat P; Moranne O; Smith C; Lundgren JD;
    J Infect Dis; 2013 May; 207(9):1359-69. PubMed ID: 23382571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy.
    Reid A; Stöhr W; Walker AS; Williams IG; Kityo C; Hughes P; Kambugu A; Gilks CF; Mugyenyi P; Munderi P; Hakim J; Gibb DM;
    Clin Infect Dis; 2008 Apr; 46(8):1271-81. PubMed ID: 18444867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of renal adverse effects of combination anti-retroviral therapy including tenofovir in HIV-infected patients.
    Tanaka H; Arai M; Tomoda Y; Wada T; Yago K; Satoh M
    J Pharm Pharm Sci; 2013; 16(3):405-13. PubMed ID: 24021289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased non-HDL-C level linked with a rapid rate of renal function decline in HIV-infected patients.
    Hara M; Yanagisawa N; Ohta A; Momoki K; Tsuchiya K; Nitta K; Ando M
    Clin Exp Nephrol; 2017 Apr; 21(2):275-282. PubMed ID: 27194410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and risk factors of mild chronic renal failure in HIV-infected patients: influence of female gender and antiretroviral therapy.
    Cristelli MP; Trullàs JC; Cofán F; Rico N; Manzardo C; Ambrosioni J; Bedini JL; Moreno A; Diekmann F; Miro JM;
    Braz J Infect Dis; 2018; 22(3):193-201. PubMed ID: 29782827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Vitamin B
    Li Y; Spence JD; Wang X; Huo Y; Xu X; Qin X
    Am J Kidney Dis; 2020 Mar; 75(3):325-332. PubMed ID: 31629573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. White blood cell count predicts the odds of kidney function decline in a Chinese community-based population.
    Fan F; Jia J; Li J; Huo Y; Zhang Y
    BMC Nephrol; 2017 Jun; 18(1):190. PubMed ID: 28592280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced renal function is associated with progression to AIDS but not with overall mortality in HIV-infected Kenyan adults not initially requiring combination antiretroviral therapy.
    Gupta SK; Ong'or WO; Shen C; Musick B; Goldman M; Wools-Kaloustian K
    J Int AIDS Soc; 2011 Jun; 14():31. PubMed ID: 21663693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.